• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类免疫缺陷病毒感染期间的球孢子菌病:在球孢子菌病流行地区的一项前瞻性研究结果

Coccidioidomycosis during human immunodeficiency virus infection: results of a prospective study in a coccidioidal endemic area.

作者信息

Ampel N M, Dols C L, Galgiani J N

机构信息

Medical Service, Tucson Veterans Affairs Medical Center, Arizona 86723.

出版信息

Am J Med. 1993 Mar;94(3):235-40. doi: 10.1016/0002-9343(93)90054-s.

DOI:10.1016/0002-9343(93)90054-s
PMID:8095771
Abstract

PURPOSE

To determine the incidence of active coccidioidomycosis among subjects infected with the human immunodeficiency virus (HIV) living in an area endemic for coccidioidomycosis and to identify factors associated with the development of active coccidioidomycosis in these patients.

PATIENTS AND METHODS

This was a prospective cohort analysis of HIV-infected subjects living in an area endemic for coccidioidomycosis in Arizona. On entry and at approximately 4-month intervals, subjects were interviewed and examined, and had spherulin skin testing and CD4 lymphocyte counts performed along with other tests. During each interval, it was determined whether the subject had developed active coccidioidomycosis according to established criteria.

RESULTS

One hundred seventy subjects entered the study. Median follow-up was 11.3 months (range: 0 to 44 months). Thirteen subjects developed active coccidioidomycosis, with an estimated cumulative incidence of 24.6% by 41 months (95% confidence limits 8.2% and 41.1%). Risk factors associated with the development of active coccidioidomycosis in the cohort were a CD4 lymphocyte count of less than 0.250 x 10(9)/L and a diagnosis of acquired immunodeficiency syndrome. Factors associated with prior coccidioidal infection, including a positive spherulin skin test, length of residence in the endemic area for more than 25 months, and a prior history of coccidioidomycosis, were not associated with the development of active infection.

CONCLUSION

Active coccidioidomycosis among individuals infected with HIV is common in the coccidioidal endemic area. Immunodeficiency appears to be the major risk factor for the development of disease. Evidence of prior coccidioidomycosis, including a positive spherulin skin test, does not appear to predict the development of active infection.

摘要

目的

确定生活在球孢子菌病流行地区的感染人类免疫缺陷病毒(HIV)的受试者中活动性球孢子菌病的发病率,并确定这些患者中与活动性球孢子菌病发生相关的因素。

患者和方法

这是一项对生活在亚利桑那州球孢子菌病流行地区的HIV感染受试者进行的前瞻性队列分析。在入组时及大约每4个月的间隔时间,对受试者进行访谈和检查,并进行球孢子菌素皮肤试验以及CD4淋巴细胞计数和其他检查。在每个间隔期,根据既定标准确定受试者是否发生了活动性球孢子菌病。

结果

170名受试者进入研究。中位随访时间为11.3个月(范围:0至44个月)。13名受试者发生了活动性球孢子菌病,到41个月时估计累积发病率为24.6%(95%置信区间为8.2%和41.1%)。该队列中与活动性球孢子菌病发生相关的危险因素是CD4淋巴细胞计数低于0.250×10⁹/L以及获得性免疫缺陷综合征的诊断。与既往球孢子菌感染相关的因素,包括球孢子菌素皮肤试验阳性、在流行地区居住超过25个月以及既往有球孢子菌病病史,均与活动性感染的发生无关。

结论

在球孢子菌病流行地区,HIV感染个体中活动性球孢子菌病很常见。免疫缺陷似乎是疾病发生的主要危险因素。既往球孢子菌病的证据,包括球孢子菌素皮肤试验阳性,似乎并不能预测活动性感染的发生。

相似文献

1
Coccidioidomycosis during human immunodeficiency virus infection: results of a prospective study in a coccidioidal endemic area.人类免疫缺陷病毒感染期间的球孢子菌病:在球孢子菌病流行地区的一项前瞻性研究结果
Am J Med. 1993 Mar;94(3):235-40. doi: 10.1016/0002-9343(93)90054-s.
2
Delayed-type hypersensitivity, in vitro T-cell responsiveness and risk of active coccidioidomycosis among HIV-infected patients living in the coccidioidal endemic area.生活在球孢子菌病流行地区的HIV感染患者的迟发型超敏反应、体外T细胞反应性及活动性球孢子菌病风险
Med Mycol. 1999 Aug;37(4):245-50.
3
Estimates of C. immitis infection by skin test reactivity in an endemic community.在地方性流行社区中,通过皮肤试验反应性对粗球孢子菌感染的估计。
Am J Public Health. 1985 Aug;75(8):863-5. doi: 10.2105/ajph.75.8.863.
4
Persistent coccidioidal seropositivity without clinical evidence of active coccidioidomycosis in patients infected with human immunodeficiency virus.感染人类免疫缺陷病毒的患者持续存在球孢子菌血清学阳性,但无活动性球孢子菌病的临床证据。
Clin Infect Dis. 1995 May;20(5):1281-5. doi: 10.1093/clinids/20.5.1281.
5
An Analysis of Skin Test Responses to Spherulin-Based Coccidioidin (Spherusol) Among a Group of Subjects with Various Forms of Active Coccidioidomycosis.一组不同形式活动性球孢子菌病患者的球孢菌属菌素(Spherusol)基于球体的皮肤试验反应分析。
Mycopathologia. 2019 Aug;184(4):533-538. doi: 10.1007/s11046-019-00356-5. Epub 2019 Jul 15.
6
Coccidioidomycosis in human immunodeficiency virus-infected patients.人类免疫缺陷病毒感染患者的球孢子菌病
J Infect Dis. 1990 Nov;162(5):1165-9. doi: 10.1093/infdis/162.5.1165.
7
Disseminated coccidioidomycosis with peritonitis in a patient with acquired immunodeficiency syndrome. Prolonged survival associated with positive skin test reactivity to coccidioidin.获得性免疫缺陷综合征患者的播散性球孢子菌病伴腹膜炎。皮肤对球孢子菌素试验反应阳性与生存期延长相关。
Arch Intern Med. 1989 Apr;149(4):947-8.
8
Coccidioidomycosis during human immunodeficiency virus infection. A review of 77 patients.人类免疫缺陷病毒感染期间的球孢子菌病。77例患者的综述。
Medicine (Baltimore). 1990 Nov;69(6):384-91. doi: 10.1097/00005792-199011000-00006.
9
Coccidioidomycosis in the acquired immunodeficiency syndrome.获得性免疫缺陷综合征中的球孢子菌病。
Ann Intern Med. 1987 Mar;106(3):372-9. doi: 10.7326/0003-4819-106-3-372.
10
Coccidioidomycosis among persons with human immunodeficiency virus infection in the era of highly active antiretroviral therapy (HAART).高效抗逆转录病毒治疗(HAART)时代人类免疫缺陷病毒感染患者中的球孢子菌病。
Semin Respir Infect. 2001 Dec;16(4):257-62. doi: 10.1053/srin.2001.29301.

引用本文的文献

1
The miRNomics of antiretroviral therapy-induced obesity.抗逆转录病毒疗法诱导肥胖的微小RNA组学
Funct Integr Genomics. 2025 Apr 5;25(1):81. doi: 10.1007/s10142-025-01585-2.
2
Challenges to Implementing a Vaccine for Coccidioidomycosis.实施球孢子菌病疫苗面临的挑战。
Open Forum Infect Dis. 2024 Feb 19;11(6):ofae095. doi: 10.1093/ofid/ofae095. eCollection 2024 Jun.
3
The Known and Unknown "Knowns" of Human Susceptibility to Coccidioidomycosis.人类对球孢子菌病易感性的已知和未知的“已知因素”
J Fungi (Basel). 2024 Mar 28;10(4):256. doi: 10.3390/jof10040256.
4
Coccidioides-Induced Pyopneumothorax in an Immunocompetent Patient.免疫功能正常患者的球孢子菌性脓气胸
Cureus. 2023 May 31;15(5):e39782. doi: 10.7759/cureus.39782. eCollection 2023 May.
5
Update on the Epidemiology, Diagnosis, and Treatment of Coccidioidomycosis.球孢子菌病的流行病学、诊断与治疗进展
J Fungi (Basel). 2022 Jun 25;8(7):666. doi: 10.3390/jof8070666.
6
Coccidioidomycosis: A Contemporary Review.球孢子菌病:当代综述
Infect Dis Ther. 2022 Apr;11(2):713-742. doi: 10.1007/s40121-022-00606-y. Epub 2022 Mar 1.
7
Coccidioidomycosis: Epidemiology, Fungal Pathogenesis, and Therapeutic Development.球孢子菌病:流行病学、真菌发病机制及治疗进展
Curr Trop Med Rep. 2019 Sep 15;6(3):132-144. doi: 10.1007/s40475-019-00184-z. Epub 2019 Jun 14.
8
Interleukin-8 Receptor 2 (IL-8R2)-Deficient Mice Are More Resistant to Pulmonary Coccidioidomycosis than Control Mice.白细胞介素-8 受体 2(IL-8R2)缺陷小鼠比对照小鼠对肺部球孢子菌病更具抵抗力。
Infect Immun. 2020 Dec 15;89(1). doi: 10.1128/IAI.00883-19.
9
Concomitant Central Nervous System Toxoplasmosis and Seronegative Disseminated Coccidioidomycosis in a Newly Diagnosed Acquired Immune Deficiency Syndrome Patient.一名新诊断的获得性免疫缺陷综合征患者合并中枢神经系统弓形虫病和血清学阴性播散性球孢子菌病
J Investig Med High Impact Case Rep. 2019 Jan-Dec;7:2324709619869372. doi: 10.1177/2324709619869372.
10
How Environmental Fungi Cause a Range of Clinical Outcomes in Susceptible Hosts.环境真菌如何导致易感宿主产生一系列临床结果。
J Mol Biol. 2019 Jul 26;431(16):2982-3009. doi: 10.1016/j.jmb.2019.05.003. Epub 2019 May 9.